Funding cuts and regulatory changes could radically reduce Medicaid, the largest program providing medical and health-related ...
“Improving prescription drug affordability for Medicare enrollees is the core of the Inflation Reduction Act, and the next ...
Trump’s executive order halts an effort to cap the copayment for generic medications at $2 for Medicare beneficiaries.
Drug pricing experts are not sure why rolling back drug pricing initiatives would be a day one priority for President Trump.
The new Trump administration should seize the opportunity to change the Medicare drug price negotiation program by ...
The rescinded order directed Medicare and Medicaid to test ways to lower drug costs for enrollees. Those tests hadn’t started ...
Federal health agencies, including CMS, have halted almost all external communication as part of the presidential transition.
The feds intend to appeal a judge's decision that would force them to recalculate UnitedHealthcare's Medicare Advantage (MA) ...
In November, a federal judge ordered CMS to recalculate UnitedHealthcare's Medicare Advantage Star Ratings for the 2025 plan ...
Federal health agencies, including the Centers for Medicare & Medicaid Services, have halted their communication efforts in ...
Experts suggest that most Americans will not experience immediate changes in their out-of-pocket health care expenses.
The newly installed Trump administration late Tuesday prompted federal health agencies, including the Centers for Medicare & Medicaid Services (CMS), ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback